In The News,
Commercial Strategy for Orphan Disease Commercial Strategy
To support the pre-launch reimbursement planning for a global pharmaceutical client’s novel orphan drug with multiple uses – including maternal fetal – ADVI developed a payor plan, a reimbursement landscape, as well as a coding strategy. Medicaid and maternal fetal health programs were evaluated to determine relative impact on drug adoption at launch. Interviews were conducted with clinicians, patients, payers, and patient advocacy representatives.
Interested in hearing more from us?
Receive customized email alerts from the ADVI team